Sacroiliac Joint Dysfunction
Conditions
Brief summary
Trial will enroll qualified subjects at a 2:1 ration to receive radiofrequency ablation or sham. At six weeks follow up they will be unblinded; sham subjects will then be given option to receive treatment. Subjects will be followed after procedure for data collection for economic outcomes and efficacy of treatment.
Detailed description
Patients presenting with low back pain associated with SIJD for longer than 6 months, and who have not had positive responsive to the conservative treatments: * Pharmacologic Management * Therapies; physical, acupuncture, massage etc… * Other alternative treatments Enrollment, Treatment/Sham Procedure, Follow-up at 3 weeks, 6 weeks with unblinding, 4, 6, 9 months. Un-blinding occurring at 6 weeks with crossover option to receive treatment. Total visits 7 with enrollment approximately over a period of 9 months. Trial extension optional for phone contact at year 1, 2. Sham subjects receiving treatment will be followed at months 6 weeks, 4, and 6 months with phone calls at year 1, 2. Patients who complete at least 50% of their patient diaries, and miss no more 2 consecutive office visits. Data will be used if patients have remained enrolled thru 4 month visit.
Interventions
None listed
Sponsors
Coastal Orthopedics & Sports Medicine
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 1\. 18 years old, or older 2. Unilateral or Bilateral LBP or Buttocks Pain for greater than six months with a 3 day average VAS greater or equal to 4 on a 1-10 scale 3. Tenderness over the SI joint 4. 75% or greater relief of pain (with return to baseline) during the local anesthetic phase of two separate, one fluoroscopically guided intra-articular SI joint injection and one lateral branch block (see Appendix A) 5. Stable medications for pain for the last seven days 6. Have used at least 3 alternative treatments for pain without success (se 7. BMI less than 35.0
Exclusion criteria
1. Focal Neurologic Signs 2. Any component of pain related to Lumbar Z-joints at L4-5 and/or L5-S1 as determined by one set of medial branch blocks 3. Previous radiofrequency procedure within the last 6 months 4. Moderate or greater spinal stenosis 5. Greater than Grade 2 listhesis 6. Foraminal Stenosis; marked to severe 7. Previous Lumbar Spine Surgery 8. Unstable Medical or Psychological Conditions as determined by the investigator 9. Concomitant cervical or thoracic pain greater than 2/10 on VAS 10. Workers compensation, disability or litigation 11. Pregnancy, breast feeding or planning on becoming pregnant during the trial 12. Subject unwillingness to complete study related activities 13. Current Smoker; unless quit greater than 6 months -
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in pain | 6 months | • To evaluate the clinical efficacy of RF lesioning of sensory innervation of the sacroiliac region as a long term treatment for pain associated with SI joint dysfunction as measured by the reduction in VAS scale and the use of pain alleviating therapies |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Economic outcomes | 1 year | • To evaluate the economic and cost benefits of radiofrequency as a treatment for chronic pain associated with SI joint pain. |
Countries
United States
Outcome results
None listed